Xing Ye

4.0k citations

122 papers · 2.9k indexed · h-index 30

Impact in

Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Cutaneous Melanoma Detection and Management
- Cancer Cells and Metastasis
- CAR-T cell therapy research
Cancer Research top 5%
- Breast Cancer Treatment Studies

Papers in ⓘ

Molecular Biology 31
- Melanoma and MAPK Pathways 5
Oncology 30
- Cutaneous Melanoma Detection and Management 7
- Cancer Immunotherapy and Biomarkers 6
- CAR-T cell therapy research 5

Co-authors: Donald L. Morton (13 shared papers)Armando E. Giuliano (8 shared papers)Dave S.�B. Hoon (7 shared papers)Richard Essner (7 shared papers)Myung‐Shin Sim (6 shared papers)Roderick R. Turner (4 shared papers)Eddy C. Hsueh (4 shared papers)Mark B. Faries (4 shared papers)
Journals: Journal of Clinical Oncology (10 papers)Annals of Surgical Oncology (6 papers)Clinical Cancer Research (3 papers)Frontiers in Microbiology (3 papers)PLoS ONE (3 papers)
Partner nations: China United States Canada

In The Last Decade

Xing Ye

112 papers receiving 2.8k citations

Peers

Countries citing papers authored by Xing Ye

Since Specialization

Citations

This map shows the geographic impact of Xing Ye's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Ye with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Ye more than expected).

Fields of papers citing papers by Xing Ye

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Ye. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Ye. The network helps show where Xing Ye may publish in the future.

Co-authors

The 25 scholars most cited alongside Xing Ye, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xing Ye Line = papers co-authored together Xing Ye links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	FOXC1 Is a Potential Prognostic Biomarker with Functional Significance in Basal-like Breast Cancer Cancer Research ·Partha Ray, Jinhua Wang, Ying Qu, Myung‐Shin Sim, Jaime Shamonki, Sanjay P. Bagaria, Xing Ye, Bingya Liu, David Elashoff, Dave S.�B. Hoon, Michael A. Walter, John W.M. Martens, Andrea L. Richardson, Armando E. Giuliano, Xiaojiang Cui	2010	199
2	Prolonged Survival After Complete Resection of Disseminated Melanoma and Active Immunotherapy With a Therapeutic Cancer Vaccine Journal of Clinical Oncology ·Eddy C. Hsueh, Richard Essner, Leland J. Foshag, David W. Ollila, Guy Gammon, Steven O’Day, Peter D. Boasberg, Stacey L. Stern, Xing Ye, Donald L. Morton	2002	163
3	Chemokine Receptor CXCR4 Expression in Patients With Melanoma and Colorectal Cancer Liver Metastases and the Association With Disease Outcome Annals of Surgery ·Joseph Kim, Takuji Mori, Steven L. Chen, Farin Amersi, Steve R. Martinez, Christine Kuo, Roderick R. Turner, Xing Ye, Anton J. Bilchik, Donald L. Morton, Dave S.�B. Hoon	2006	147
4	Impact of Micrometastases in the Sentinel Node of Patients With Invasive Breast Cancer Journal of Clinical Oncology ·Nora Hansen, Baiba J. Grube, Xing Ye, Roderick R. Turner, R. James Brenner, Myung‐Shin Sim, Armando E. Giuliano	2009	127
5	B7–H3 Ligand Expression by Primary Breast Cancer and Associated With Regional Nodal Metastasis Annals of Surgery ·Takaaki Arigami, Norihiko Narita, Ryuichi Mizuno, Linhda Nguyen, Xing Ye, Alice Chung, Armando E. Giuliano, Dave S.�B. Hoon	2010	121
6	Isolated Tumor Cells in the Sentinel Node Affect Long-Term Prognosis of Patients with Melanoma Annals of Surgical Oncology ·Randall P. Scheri, Richard Essner, Roderick R. Turner, Xing Ye, Donald L. Morton	2007	90
7	Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes Clinical Cancer Research ·Taku Nakagawa, Steve R. Martinez, Yasufumi Goto, Kazuo Koyanagi, Minoru Kitago, Tatsushi Shingai, David Elashoff, Xing Ye, Frederick R. Singer, Armando E. Giuliano, Dave S.�B. Hoon	2007	83
8	Enhanced Survival Associated with Vitiligo Expression during Maintenance Biotherapy for Metastatic Melanoma Journal of Investigative Dermatology ·Peter D. Boasberg, Dave S.�B. Hoon, Lawrence D. Piro, Maureen Martin, Akhide Fujimoto, Timothy S. Kristedja, Sandeep Bhachu, Xing Ye, Regina Deck, Steven O’Day	2006	79
9	Pembrolizumab plus best supportive care versus placebo plus best supportive care as second-line therapy in patients in Asia with advanced hepatocellular carcinoma (HCC): Phase 3 KEYNOTE-394 study. Journal of Clinical Oncology ·Shukui Qin, Zhendong Chen, Weijia Fang, Zhenggang Ren, Ruocai Xu, Baek‐Yeol Ryoo, Zhiqiang Meng, Yuxian Bai, Xiaohong Chen, Xiufeng Liu, Juxiang Xiao, Gwo Fuang Ho, Yimin Mao, Xing Ye, Jieer Ying, Jianfeng Li, Wen Yan Zhong, Yu Zhou, Abby B. Siegel, Chunyi Hao	2022	79
10	Personalizing Breast Cancer Staging by the Inclusion of ER, PR, and HER2 JAMA Surgery ·Sanjay P. Bagaria, Partha Ray, Myung‐Shin Sim, Xing Ye, Jaime Shamonki, Xiaojiang Cui, Armando E. Giuliano	2013	76
11	Effect of Granulocyte/Macrophage Colony-Stimulating Factor on Vaccination with an Allogeneic Whole-Cell Melanoma Vaccine Clinical Cancer Research ·Mark B. Faries, Eddy C. Hsueh, Xing Ye, Mary T. Hoban, Donald L. Morton	2009	75
12	Prolonged survival after complete resection of metastases from intraocular melanoma Cancer ·Eddy C. Hsueh, Richard Essner, Leland J. Foshag, Xing Ye, He‐Jing Wang, Donald L. Morton	2003	67
13	A STUDY ON OXIDATIVE STRESS IN LEAD-EXPOSED WORKERS Journal of Toxicology and Environmental Health ·Xing Ye	1999	64
14	CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers Journal of Clinical Oncology ·Peter C. Enzinger, Barbara Burtness, Donna Niedzwiecki, Xing Ye, Kathe Douglas, David H. Ilson, Victoria Villaflor, Steven J. Cohen, Robert J. Mayer, Alan P. Venook, Al B. Benson, Richard M. Goldberg	2016	59
15	Late Recurrence in Melanoma: Clinical Implications of Lost Dormancy Journal of the American College of Surgeons ·Mark B. Faries, Shawn Steen, Xing Ye, Myung‐Shin Sim, Donald L. Morton	2013	58
16	Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance) PLoS ONE ·Michael Fuchs, Kaori Sato, Donna Niedzwiecki, Xing Ye, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, Renaud Whittom, Alexander Hantel, Al B. Benson, Daniel Atienza, Michael J. Messino, Hedy L. Kindler, Alan P. Venook, Shuji Ogino, Kana Wu, Walter C. Willett, Edward L. Giovannucci, Jeffrey A. Meyerhardt	2014	57
17	The clinical significance of MAGEA3 expression in pancreatic cancer International Journal of Cancer ·Joseph Kim, Howard A. Reber, O. Joe Hines, Kevork Kazanjian, Andy N. Tran, Xing Ye, Farin Amersi, Steve R. Martinez, Sarah Dry, Anton J. Bilchik, Dave S.�B. Hoon	2005	54
18	Marine ω-3 Polyunsaturated Fatty Acid and Fish Intake after Colon Cancer Diagnosis and Survival: CALGB 89803 (Alliance) Cancer Epidemiology Biomarkers & Prevention ·Erin L. Van Blarigan, Charles S. Fuchs, Donna Niedzwiecki, Xing Ye, Sui Zhang, Mingyang Song, Leonard B. Saltz, Robert J. Mayer, Rex B. Mowat, Renaud Whittom, Alexander Hantel, Al B. Benson, Daniel Atienza, Michael J. Messino, Hedy L. Kindler, Alan P. Venook, Shuji Ogino, Edward L. Giovannucci, Jeffrey A. Meyerhardt	2018	50
19	Lotus pollen-derived hierarchically porous carbons with exceptional adsorption performance toward Reactive Black 5: Isotherms, kinetics and thermodynamics investigations Separation and Purification Technology ·Xing Ye, Ling Wu, Meiwen Zhu, Zhipeng Wang, Zheng‐Hong Huang, Mingxi Wang	2022	50
20	Using miRNAs and circRNAs to estimate PMI in advanced stage Legal Medicine ·Chunyan Tu, Tieshuai Du, Xing Ye, Chengchen Shao, Jianhui Xie, Yiwen Shen	2019	41

About Xing Ye

Xing Ye is a scholar working on Molecular Biology, Oncology, Immunology, Materials Chemistry and Cancer Research, having authored 122 papers that have together received 2.9k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (11 papers), Breast Cancer Treatment Studies (7 papers), Aquaculture disease management and microbiota (7 papers), Cutaneous Melanoma Detection and Management (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Aquaculture Nutrition and Growth (6 papers), Melanoma and MAPK Pathways (5 papers) and CAR-T cell therapy research (5 papers). The work is most often cited by research in Oncology (1.2k citations), Cancer Research (548 citations), Immunology (658 citations), Molecular Biology (930 citations) and Pathology and Forensic Medicine (225 citations). Xing Ye has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Donald L. Morton, Armando E. Giuliano, Dave S.�B. Hoon, Richard Essner, Myung‐Shin Sim, Roderick R. Turner, Eddy C. Hsueh, Mark B. Faries, Sanjay P. Bagaria and Leland J. Foshag. Their work appears in journals such as Journal of Clinical Oncology, Annals of Surgical Oncology, Clinical Cancer Research, Frontiers in Microbiology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact